Dennis Mutua

Ant Group Receives Approval for Its Hong Kong Leg Dual Listing

China based financial technology company Ant Group Co Ltd announced having received an approval from China’s securities regulator for its upcoming Hong Kong leg dual listing which is estimated to fetch around $35 billion. The company is planning to simultaneously get listed in the Hong Kong and Shanghai stock markets. Insider sources revealed the company […]

IBM Surpasses Analysts’ Estimates in Third Quarter Results

U.S based Technology Company and cloud platform International Business Machine (IBM) posted its third quarter results fairly soaring above analysts’ revenue estimates in the quarter. The company attributed the good performance to high demand of its cloud business. According to IBM’s chief financial officer James Kavanaugh, there are some consumer behaviors which tend to work […]

China Reviews Laws Reinforcing Protection of Minors Online

The parliament of China revised laws concerning protection of persons under 18 online. According to the news first posted by state news agency Xinhua, providers of content and products online in China will be forced to take action if the situation concerns under 18’s. The National People Congress Standing Committee voted for adoption of the […]

Thailand Bans Demonstrations as Protests against Top Government Official Spikes

The government of Thailand has banned demonstrations and protests of whatever nature across the country due to increasing demonstrations against King Maha Vajiralongkorn and Prime Minister Prayuth Chan-ocha. The latest protests on the same took place on October 15 resulting whereby thousands of Thailand citizens turned up in the streets to protests. The situation escalated […]

Blackstone Selling BioMed in a Deal Worth $14.6 Billion

Leading company in real estate investing Blackstone Real Estate Partners announced that together with its co-investors they have discussed and resolved to sell self-administered and self-managed real estate investment company BioMed Realty Trust Inc. (BMR) for a price of $14.6 billion. Blackstone will be selling the entity to a group led by existing investors in […]

Twitter Suspends Accounts of Trump’s Black Supporters Says They Broke Rules

Social network Twitter Inc. (TWTR) has suspend several accounts belonging to black supporters of U.S President Donald Trump and his re-election bid in the upcoming presidential elections claiming the account owners broke its rules on manipulation and spam. The accounts in question have been frequently posting pictures of individuals which do not match with their […]

Solar Company Array Technologies Raises $1 Billion from its IPO

Solar power equipment manufacturer Array Technologies conducted its initial public offering on October 14 raising $1.05 billion from it. Once the company goes public it will be trading under the ticker symbol ARRY in NASDAQ. The U.S based company priced its shares at $22 per share in the IPO selling 47.5 million shares hence fetching […]

Aimmune Stakeholders Okays $2 Billion Nestle Offer

Shareholders of biotechnology company Aimmune Therapeutics Inc. (AIMT) have thrown their support behind a $2 billion tender offer from Swiss food and drink processing company Nestle SA (SWX: NESN) to gain entire ownership of the first peanut allergy treatment approved by the United States. Launch of the peanut allergy treatment has been sluggish due to […]

World Bank Approves $12 Billion to Fund COVID-19 Vaccines for Developing Countries

The World Bank announced that its executive board approved $12 billion to fund purchasing and distribution of COVID-19 vaccine across third world countries once a suitable vaccine will be released. Developing countries will also use the cash to test and treat the disease, World Bank’s executive board approved the funding plan on October 13. This […]

J&J Halts COVID-19 Vaccines Trials After a Participants Suffers Unexplained Illness

American based medical device and pharmaceutical company Johnson & Johnson (J&J) has temporarily halted had its COVID-19 vaccine clinical trials after a study candidate started suffering from unknown illness. In a statement the company said the participant in question is being evaluated and reviewed by an independent data and safety monitoring board together with the […]